文献速递眼底病与葡萄膜炎

视网膜临床实践中Snellen视力测量与电子ETDRS方案视力评估的比较

Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment.
PubMed 文献 · Ophthalmology · 2022-12-12

该回顾性图表综述分析了DRCR视网膜网络AC、AE和W方案中1016只眼(511名参与者)的临床Snellen视力与eETDRS方案视力的差异。结果显示,方案视力平均比临床视力好7.6个字母(约1至2行),临床视力较低和未矫正屈光的眼差异更大。作者认为,在临床中矫正屈光可能有助于基于视力制定治疗计划和转诊研究。

要点

  • 临床Snellen视力平均比eETDRS方案视力差7.6个字母(约1至2行)。
  • 临床视力≤20/50的眼差异为10.7个字母,≥20/40的眼差异为5.8个字母。
  • 未矫正屈光眼的差异为9.8个字母,高于矫正屈光、眼镜/接触镜或针孔矫正的差异。

核心结论

  • 平均而言,临床Snellen视力比eETDRS方案屈光和视力测试差1至2行,这可能部分解释临床实践不总能复制临床试验结果。
  • 临床测量值较低和未进行临床屈光矫正的眼倾向于有更大的差异。
  • 考虑到临床和方案视力测量之间的潜在差异,在临床中矫正屈光可能有利于基于视力确定治疗计划和转诊研究。

研究设计与样本

  • 回顾性图表综述,纳入DRCR视网膜网络AC、AE(糖尿病黄斑水肿)和W(非增殖性糖尿病视网膜病变)方案参与者的研究眼和对侧眼,其临床视力在方案访视前3个月内记录。

主要发现

  • 共分析74个中心1016只眼(511名参与者)的数据,临床访视平均视力为68.6个字母(Snellen等效20/50),方案访视平均视力为76.3个字母(Snellen等效20/32),两次访视平均间隔26天(标准差21天)。
  • 方案视力平均(标准差)比临床视力好7.6(9.6)个字母;临床视力≤20/50的眼(n=376)好10.7(12.6)个字母,临床视力≥20/40的眼(n=640)好5.8(6.6)个字母。
  • 临床视力每增加1行(5个字母),临床与方案视力差异平均缩小1.3个字母(P<0.001)。
  • 按临床屈光矫正方式,平均(标准差)差异为:矫正屈光3.9(9.0)个字母,眼镜/接触镜6.9(9.2)个字母,针孔7.9(11.5)个字母,未矫正9.8(9.3)个字母(P=0.06)。

临床怎么用

  • 作者认为,考虑到临床和方案视力测量之间的潜在差异,在临床中矫正屈光可能有利于基于视力确定治疗计划和转诊研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Evaluate the differences between clinical visual acuity (VA) as recorded in medical records and electronic Early Treatment Diabetic Retinopathy Study (eETDRS) protocol VA measurements and factors affecting the size of the differences. DESIGN: Retrospective chart review. PARTICIPANTS: Study and fellow eyes of participants enrolled in DRCR Retina Network Protocols AC and AE (diabetic macular edema), and W (nonproliferative diabetic retinopathy) with clinical VA recorded within 3 months before the protocol visit. METHODS: Differences and their association with patient and ocular factors were evaluated using linear mixed models with random effects for correlations within sites and participants. MAIN OUTCOME MEASURE: Difference between VA letter scores measured by eETDRS during a study visit versus measured by Snellen during a regular clinical visit (Snellen fraction converted to eETDRS). RESULTS: Data from 1016 eyes (511 participants) across 74 sites were analyzed. The mean VA measurements were 68.6 letters (Snellen equivalent 20/50) at the clinical visit and 76.3 letters (Snellen equivalent 20/32) at the protocol visit, with a mean (standard deviation [SD]) of 26 (21) days between visits. Mean (SD) protocol VA was better than clinical VA by 7.6 (9.6) letters overall, 10.7 (12.6) letters in eyes with clinical VA ≤ 20/50 (n = 376), and 5.8 (6.6) letters in eyes with clinical VA ≥ 20/40 (n = 640). On average, the difference between clinical and protocol VA was 1.3 letters smaller for every 1-line (5 letters) increase in clinical VA (P < 0.001). Mean (SD) differences by clinical correction of refractive error were 3.9 (9.0) letters with refraction, 6.9 (9.2) letters with glasses/contact lenses, 7.9 (11.5) letters with pinhole, and 9.8 (9.3) letters without correction (P = 0.06). CONCLUSIONS: On average, clinical Snellen VA is 1 to 2 lines worse than eETDRS protocol refraction and VA testing, which may partly explain why clinical practice does not always replicate clinical trial results. Eyes with lower clinical measurements and eyes tested without clinical refraction tended to have larger differences. Considering the potential discrepancies between clinical and protocol VA measurements, refracting eyes in the clinic may benefit patients when determining treatment plans and study referrals based on vision. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Baker CW, Josic K, Maguire MG, et al. Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment. Ophthalmology. 2022. PMID: 36521571. doi:10.1016/j.ophtha.2022.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。